Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter.
暂无分享,去创建一个
D. Baim | J. Popma | D. Cohen | B. George | R. Kuntz | J. Carrozza | K. Dandreo | S. Ramee | A. Lansky | D. McCormick | Jose A. Silva | C. Setum | J. A. Silva | D. Cohen | David J. Cohen | Barry S. George | Jose A. Silva | Alexandra A. Lansky | Kim Dandreo | Daniel J. McCormick | Alexandra Lansky
[1] Marshall A. Lichtman,et al. Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961 , 2000 .
[2] H. S,et al. Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2000 .
[3] Bruce R. Brodie,et al. Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .
[4] S. Greenhouse,et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial , 1999 .
[5] A. Jacobs,et al. Primary PTCA versus thrombolytic therapy: an evidence-based summary. , 1999, American heart journal.
[6] D. Baim,et al. Rheolytic thrombectomy with the Possis AngioJet: technical considerations and initial clinical experience. , 1999, The Journal of invasive cardiology.
[7] C. White,et al. Rheolytic thrombectomy: A new treatment for stent thrombosis , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[8] J. Burchenal,et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. , 1998, Circulation.
[9] D. Antoniucci,et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. , 1998, Journal of the American College of Cardiology.
[10] David P Miller,et al. Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators. , 1998, Circulation.
[11] Stone Gw. Stenting in Acute Myocardial Infarction: Observational Studies and Randomized Trials Ñ 1998. , 1998 .
[12] J. Burchenal,et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. , 1998, Circulation.
[13] R. Califf,et al. Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications. , 1998, Journal of the American College of Cardiology.
[14] M. Simoons,et al. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.
[15] Epilog Investigators,et al. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.
[16] U. Rosenschein,et al. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial). Results of the feasibility phase. , 1997, Circulation.
[17] J. Webb,et al. Usefulness of coronary stenting for cardiogenic shock. , 1997, The American journal of cardiology.
[18] W. O’Neill,et al. Prospective study of extraction atherectomy in patients with acute myocardial infarction. , 1996, The American journal of cardiology.
[19] P. Serruys,et al. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coronary angioplasty: a quantitative angiographic analysis. , 1996, Circulation.
[20] D. Baim,et al. Preliminary experience with the POSSIS coronary AngioJet rheolytic thrombectomy catheter in the VeGAS I pilot study , 1996 .
[21] P. Teirstein,et al. Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. , 1996, Circulation.
[22] C. Bauters,et al. Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis. , 1995, Circulation.
[23] J. O’Keefe,et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. , 1995, Journal of the American College of Cardiology.
[24] W. O’Neill,et al. Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries. , 1995, Journal of the American College of Cardiology.
[25] J. Marmur,et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial. , 1994, Circulation.
[26] Epic Investigators,et al. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.
[27] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[28] J. Reiber,et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.
[29] K. Bailey,et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.
[30] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[31] E. Braunwald,et al. Coronary Angioplasty Performed Within the Thrombolysis in Myocardial Infarction II Study , 1992, Circulation.
[32] H. Lambertz,et al. THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.
[33] D. Holmes,et al. Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. , 1985, Journal of the American College of Cardiology.
[34] R. Gabriel. IgA DEFICIENCY, HYPERTENSION, AND MULTICYSTIC RENAL DISEASE , 1976, The Lancet.